Saptarshi Mukherjee¹ and Ishani Ganguly²*

¹M. Tech, Nanotechnology, Guru Gobind Singh Indraprastha University, India
²Academic Coordinator, FSTN Exploration Foundation, India

*Corresponding Author: Saptarshi Mukherjee, M. Tech, Nanotechnology, Guru Gobind Singh Indraprastha University, India.

Received: November 06, 2024; Published: April 22, 2025

Abstract

Telemedicine is the remote practice of medicine through the use of information and communication technologies for the prevention, diagnosis, treatment and the management of various communicable and non-communicable diseases related to paediatrics. There is widespread use of telemedicine for the management of the acute and chronic infectious diseases. It is particularly found in those countries in which the majority of the population are living in the rural areas, far away from the third-level hospital center that are located in large urban areas. Obviously, telemedicine is being used in the developing countries. Telemedicine is increasingly representing the future and the beginning of the new era of healthcare system that will redefine the medical care for the treatment of infectious diseases, both acute and the chronic conditions in children.

Keywords: Paediatric Infectious Disease; Telemedicine; Digital Health Technology; Patient Diagnosis; Rural Patients; New Medical Treatment

References

1. Simoes EAF., et al. “Acute Respiratory Infections in Children, in Disease Control Priorities in Developing Countries, D.T. Jamison, et al. Editors. 2006, The International Bank for Reconstruction and Development / The World Bank-Oxford University Press-Copyright © 2006, The International Bank for Reconstruction and Development/The World Bank Group.: Washington (DC)-New York (2006).
2. Bhutta ZA and MA Saeed. “Childhood Infectious Diseases: Overview”. International Encyclopedia of Public Health, (2008): 620-640.
3. Hammer CC., et al. “Risk factors and risk factor cascades for communicable disease outbreaks in complex humanitarian emergencies: a qualitative systematic review”. BMJ Global Health4 (2018): e000647.
4. Boyce MR., et al. “Risk Factors for Infectious Diseases in Urban Environments of Sub-Saharan Africa: A Systematic Review and Critical Appraisal of Evidence”. Tropical Medicine and Infectious Disease4 (2019).
5. Dawkins B., et al. “What factors affect patients' ability to access healthcare? An overview of systematic reviews”. Tropical Medicine and International Health10 (2021): 1177-1188.
6. Ronquillo Y., et al. “Digital Health, in StatPearls”. 2023, StatPearls Publishing (2023). Copyright © 2023, StatPearls Publishing LLC.: Treasure Island (FL) ineligible companies. Disclosure: Arlen Meyers declares no relevant financial relationships with ineligible companies. Disclosure: Scott Korvek declares no relevant financial relationships with ineligible companies (2023).
7. Ryu S. “Telemedicine: Opportunities and Developments in Member States: Report on the Second Global Survey on eHealth 2009 (Global Observatory for eHealth Series, Volume 2)”. Healthcare Information Research 2 (2012): 153-5.
8. Young JD., et al. “Infectious Diseases Society of America Position Statement on Telehealth and Telemedicine as Applied to the Practice of Infectious Diseases”. Clinical Infectious Disease9 (2019): 1437-1443.
9. Parmar P., et al. “Use of Telemedicine Technologies in the Management of Infectious Diseases: A Review”. Clinical Infectious Diseases7 (2014): 1084-1094.
10. Andrews R., et al. “Configurations of new public management reforms and the efficiency, effectiveness and equity of public healthcare systems: a fuzzy-set qualitative comparative analysis”. Public Management Review8 (2019): 1236-1260.
11. Lesher AP and Shah SR. “Telemedicine in the perioperative experience”. Seminar on Pediatric Surgery2 (2018): 102-106.
12. Burke Jr BL., et al. “Section on Telehealth Care Telemedicine: Pediatric applications”. Pediatrics1 (2015): e293-e308.
13. Katzow MW., et al. “Telemedicine and health disparities during COVID-19”. Pediatrics2 (2020): e20201586.
14. Dong Y., et al. “Epidemiology of COVID-19 Among Children in China”. Pediatrics 6 (2020).
15. Badawy SM., et al. “Technology Access and Smartphone App Preferences for Medication Adherence in Adolescents and Young Adults With Sickle Cell Disease”. Pediatric Blood Cancer5 (2016): 848-852.
16. Badawy SM., et al. “Medication Adherence and Technology-Based Interventions for Adolescents With Chronic Health Conditions: A Few Key Considerations”. JMIR Mhealth Uhealth12 (2017): e202.
17. Fedele DA., et al. “Mobile Health Interventions for Improving Health Outcomes in Youth: A eta-analysis”. JAMA Pediatrics5 (2017): 461-469.
18. Burke BL and Hall RW. “Section on Telehealth Care Telemedicine: Pediatric Applications”. Pediatrics 1 (2015): e293-308.
19. Committee on Pediatric Workforce. Marcin JP, Rimsza ME, Moskowitz WB. “The Use of Telemedicine to Address Access and Physician Workforce Shortages”. Pediatrics1 (2015): 202-209.
20. American Academy of Pediatrics. [2020-06-11]. Supporting Pediatric Research on Outcomes and Utilization of Telehealth (SPROUT).
21. Gattu R., et al. “Telemedicine applications for the pediatric emergency medicine: A review of the current literature”. Pediatric Emergency Care2 (2016): 123-130.
22. Brophy PD. “Overview on the challenges and benefits of using telehealth tools in a pediatric population”. Advances in Chronic Kidney Disease1 (2017): 17-21.
23. Combi C., et al. “Telemedicine for developing countries. A survey and some design issues”. Applied Clinical Informatics4 (2016): 1025-1050.
24. Wang TT., et al. “Assessment of utilization and cost-effectiveness of telemedicine program in western regions of China: A 12-year study of 249 hospitals across 112 cities”. Telemedicine and e-Health11 (2016): 909-920.
25. Sasangohar F., et al. “Remote patient monitoring and telemedicine in neonatal and pediatric settings: Scoping literature review”. Journal of Medical Internet Research12 (2018): e295.
26. de Jong MJ., et al. “Telemedicine for management of inflammatory bowel disease (myIBDcoach): a pragmatic, multicentre, randomised controlled trial”. Lancet 10098 (2017): 959-968.
27. Chongmelaxme B., et al. “The effects of telemedicine on asthma control and patients' quality of life in adults: A systematic review and meta-analysis”. The Journal of Allergy and Clinical Immunology: In Practice1 (2019): 199-216.e11.
28. Stanberry B. “Telemedicine: barriers and opportunities in the 21st century”. Journal of Internal Medicine6 (2000): 615-628.
29. Ray KN., et al. “Optimizing telehealth strategies for subspecialty care: recommendations from rural pediatricians”. Telemedicine and e-Health8 (2015): 622-629.
30. Avdalovic MV and Marcin JP. “When will telemedicine appear in the ICU?” Journal of Intensive Care Medicine4 (2019): 271-276.
31. Schneider RB and Biglan KM. “The promise of telemedicine for chronic neurological disorders: the example of Parkinson's disease”. Lancet Neurology7 (2017): 541-551.
32. Siegel CA. “Transforming gastroenterology care with telemedicine”. Gastroenterology 5 (2017): 958-963.
33. Bartolucci AA and Hillegass WB. “Overview, strengths, and limitations of systematic reviews and meta-Analyses”. In: Chiappelli F, editor. Evidence-Based Practice: Toward Optimizing Clinical Outcomes. Berlin, Heidelberg: Springer (2010).

Citation

Citation: Saptarshi Mukherjee and Ishani Ganguly. “Telemedicine in Paediatric Infectious Diseases".Acta Scientific Microbiology 8.5 (2025): 67-73.

Copyright

Copyright: © 2025 Saptarshi Mukherjee and Ishani Ganguly. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.